New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
IntroductionPancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a poor survival outcome. Predicting patient survival allows physicians to tailor treatments to specific individuals. Thus, a simple and cost-effective prognosis model is sorely needed.MethodsThis retrospective study assesses...
Saved in:
Main Authors: | Rocío del Campo-Pedrosa, Alfonso Martín-Carnicero, Ana González-Marcos, Alfredo Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1411096/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
by: Rocío del Campo-Pedrosa, et al.
Published: (2025-01-01) -
The Association Between Serum Gamma‐Glutamyl Transferase and Gastrointestinal Cancer Risk: A Systematic Review and Meta‐Analysis
by: Alireza Ramandi, et al.
Published: (2025-01-01) -
Association between risk of ischemic stroke and liver enzymes levels: a systematic review and meta-analysis
by: Omnia Samy El-Sayed, et al.
Published: (2025-01-01) -
γ-Gammaglutamyl transferase predicts all-cause mortality within three-year intervals in patients undergoing peritoneal dialysis
by: Yan-Bing Chen, et al.
Published: (2024-12-01) -
GSTP1, GSTM1 and GSTT1 genetic polymorphisms and total serum GST concentration in stable male COPD
by: Žuntar Irena, et al.
Published: (2014-03-01)